William D Tap

Title: William D. Tap: Innovator in Cancer Diagnostics

Introduction

William D. Tap is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer diagnostics, particularly in the development of companion diagnostics for CDK4 inhibitors. His work aims to enhance the effectiveness of cancer treatments by utilizing specific biomarkers.

Latest Patents

William D. Tap holds a patent for "Enigma and CDH18 as companion diagnostics for CDK4 inhibitors." This patent relates to the use of one or more biomarkers to evaluate the likelihood that a CDK4 inhibitor would produce an anti-cancer effect in a subject. The disclosure provides methods, compositions, and kits for a companion diagnostic for CDK4 inhibitors. It emphasizes the importance of the colocalization of Enigma and CDH18 biomarkers to foci within cancer, which can determine whether the cancer can be successfully treated by CDK4 inhibition. He has 1 patent to his name.

Career Highlights

William D. Tap is affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to advance research in cancer treatment. His work is instrumental in bridging the gap between innovative diagnostics and practical applications in oncology.

Collaborations

He collaborates with esteemed colleagues, including Mary Elizabeth Dooley and Marta Kovatcheva, to further enhance the impact of his research in the medical field.

Conclusion

William D. Tap's contributions to cancer diagnostics through his innovative patent demonstrate his commitment to improving treatment outcomes for patients. His work at Memorial Sloan Kettering Cancer Center continues to pave the way for advancements in oncology.